...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Urinary metabonomics characterization of liver fibrosis induced by CCl4 in rats and intervention effects of Xia Yu Xue Decoction
【24h】

Urinary metabonomics characterization of liver fibrosis induced by CCl4 in rats and intervention effects of Xia Yu Xue Decoction

机译:CCl4诱导大鼠肝纤维化的尿代谢组学特征及下鱼血汤的干预作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Xia Yu Xue Decoction (XYXD) is a traditional Chinese medicine which has been widely used in clinic practice for treating liver disease. However, its mechanism of action remains unknown. In this study, a urinary metabonomic method, based on gas chromatography coupled with mass spectrometry (GC/MS), was developed to investigate the effect of XYXD on liver fibrosis. Pattern recognition analysis, including principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA), showed that metabolic perturbations induced by CCl4 were restored after treatment with XYXD. Ten potential biomarkers associated with modulation of energy metabolism, microflora metabolism, amino acid and fatty acid metabolism were identified, suggesting that the mechanism of action of XYXD may involve these processes. Our findings indicate that metabonomic methods based on GC/MS may provide a useful means of exploring biomarkers involved in liver fibrosis and for elucidating the mechanisms of action of therapies used in traditional Chinese medicine.
机译:霞鱼血汤(XYXD)是一种中药,已广泛用于临床治疗肝病。但是,其作用机理仍然未知。在这项研究中,开发了一种基于气相色谱-质谱联用(GC / MS)的尿液代谢组学方法,以研究XYXD对肝纤维化的影响。模式识别分析(包括主成分分析(PCA)和偏最小二乘判别分析(PLS-DA))显示,使用XYXD处理后,由CCl4引起的代谢扰动得以恢复。与能量代谢,微生物区系代谢,氨基酸和脂肪酸代谢调节相关的十种潜在生物标记被确定,表明XYXD的作用机制可能涉及这些过程。我们的发现表明,基于GC / MS的代谢组学方法可能为探索参与肝纤维化的生物标志物以及阐明中药疗法的作用机理提供有用的手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号